Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Nerve Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04580979
What this trial is testing

Natural History Study of FDXR Mutation-related Mitochondriopathy

Who this might be right for
Neurodegenerative Disease, HereditaryMitochondrial DiseasesOptic Atrophy
State University of New York at Buffalo 33
Large-scale testing (Phase 3)Ended earlyNCT01187888
What this trial is testing

Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy
Prof. Dr. Stefan Lorenzl 44
Testing effectiveness (Phase 2)UnknownNCT04734379
What this trial is testing

Rho Kinase (ROCK) Inhibitor in Tauopathies - 1

Who this might be right for
Progressive Supranuclear PalsyCorticobasal Syndrome
Woolsey Pharmaceuticals 15
Testing effectiveness (Phase 2)Study completedNCT00328874
What this trial is testing

Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy
German Parkinson Study Group (GPS) 20
Not applicableStudy completedNCT02236832
What this trial is testing

Study of the Neural Basis of Analogical Reasoning

Who this might be right for
Frontotemporal DementiaProgressive Supranuclear PalsyHealthy Subjects
Institut National de la Santé Et de la Recherche Médicale, France 130
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Not applicableUnknownNCT04695015
What this trial is testing

Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm

Who this might be right for
Melanoma (Skin)Melanoma in SituNevus Eye+4 more
Peking University 100
Not applicableLooking for participantsNCT02194816
What this trial is testing

Modifiable Variables in Parkinsonism (MVP)

Who this might be right for
Parkinson's DiseaseParkinsonismMSA - Multiple System Atrophy+6 more
Bastyr University 2,000
Not applicableStudy completedNCT04195711
What this trial is testing

Comparative Validation of "Blinq" and "2WIN" Vision Screeners

Who this might be right for
Strabismic AmblyopiaRefractive AmblyopiaStrabismus
Alaska Blind Child Discovery 100
Not applicableLooking for participantsNCT04634383
What this trial is testing

A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness

Who this might be right for
Ocular InjuryOptic Nerve DiseasesPhotoreceptor Degeneration+1 more
Illinois Institute of Technology 5
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Not applicableStudy completedNCT05501431
What this trial is testing

Personalized Parkinson Project PSP Cohort

Who this might be right for
Progressive Supranuclear PalsyBrain DiseasesNeurodegenerative Diseases+1 more
Radboud University Medical Center 100
Not applicableNot Yet RecruitingNCT06155942
What this trial is testing

Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes

Who this might be right for
Parkinson DiseaseProgressive Supranuclear Palsy
Assistance Publique Hopitaux De Marseille 63
Early research (Phase 1)Study completedNCT04715750
What this trial is testing

Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Who this might be right for
Alzheimer DiseaseProgressive Supranuclear Palsy
Life Molecular Imaging GmbH 10
Not applicableStudy completedNCT00918190
What this trial is testing

Late Onset Postoperative Nausea and Vomiting

Who this might be right for
Postoperative Nausea and Vomiting
King Khaled Eye Specialist Hospital 75
Not applicableUnknownNCT05130385
What this trial is testing

High Resolution Optical Coherence Tomography

Who this might be right for
Retinal DiseaseRetinal DetachmentRetinal Vein Occlusion+13 more
Insel Gruppe AG, University Hospital Bern 550
Testing effectiveness (Phase 2)WithdrawnNCT04184518
What this trial is testing

Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma

Who this might be right for
Uveal MelanomaMetastatic Cancer
Grupo Español Multidisciplinar de Melanoma
Not applicableStudy completedNCT01804452
What this trial is testing

4 Repeat Tauopathy Neuroimaging Initiative

Who this might be right for
Progressive Supranuclear PalsyCorticobasal Degeneration
University of California, San Francisco 110
Early research (Phase 1)Study completedNCT03888716
What this trial is testing

A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease

Who this might be right for
Mitochondrial DiseasesMitochondrial Respiratory Chain DeficienciesMELAS Syndrome+1 more
Abliva AB 72
Not applicableStudy completedNCT02734485
What this trial is testing

Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear PalsyParkinson's Disease
IRCCS San Raffaele Roma 20
Next Page